MINERALYS, IN WONDERLAND? A lot of positivity swirling around this Aldosterone and Hypertension focused biotech.
1. Multiple recent positive top line results
2. recent Influx of capital for development, manufacturing and pre-commercialization activities
3. recent insider buying
4. increasing price and volume
I got lucky when buying in at $13, and was able to largely de-risk at 17. Currently a bit oversold, so on current trajectory watch and wait for a pullback to a better entry below $14.
Please also note the current market conditions indicate cautious buying, and while this may end up being a great biotech, a much larger percentage of these types of stocks will fail.
May the Fed be with you!
Not financial advice.
